Inovio Pharmaceuticals Inc (INO)
1.79
-0.04
(-2.19%)
USD |
NASDAQ |
Dec 23, 12:20
Inovio Pharmaceuticals Free Cash Flow: -111.18M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Novavax Inc | -112.35M |
| Baxter International Inc | 391.00M |
| Candel Therapeutics Inc | -28.69M |
| AIM ImmunoTech Inc | -21.33M |
| Protalix BioTherapeutics Inc | 7.171M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -27.44M |
| Cash from Investing (Quarterly) | 14.08M |
| Cash from Financing (Quarterly) | 0.6606M |
| Free Cash Flow Per Share (Quarterly) | -0.9752 |
| Free Cash Flow Yield | -245.1% |